1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Molgramostim Open-label: new trials by email Literature Review of Molgramostim Open-label trials Research Report on Molgramostim Open-label
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Molgramostim, Placebo, Molgramostim Open-label - Autoimmune Pulmonary Alveolar Proteinosis | Phase 3 | Active not recruiting | Savara Inc. | 164 | 2021-05-19 | 2026-11-03 |
Pulmonary Alveolar Proteinosis, Acquired (1)
Savara Inc. (1)
Australia (1) · Belgium (1) · Canada (1) · France (1) · Germany (1) · Greece (1) · Ireland (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · Portugal (1) · Romania (1) · South Korea (1) · Spain (1)